Articles: chronic.
-
The Effect of Serum Vitamin D Level in Korean Chronic Obstructive Pulmonary Disease (COPD) Patients.
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To determine the relationship of serum vitamin D level with lung function, acute exacerbation, 6 minute walking (6MW) distance, and quality of life. ⋯ The following authors have nothing to disclose: Ji Ye Jung, Ah Young Leem, Eu Dong Hwang, Song Yee Kim, Se Kyu Kim, Joon ChangNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Monday, March 24, 2014 at 09:00 AM - 10:00 AMPURPOSE: Our goal has been to assess the presence of neoplasms in a cohort of COPD patients, to describe their clinical and epidemiological characteristics and observe if there are differences between COPD patients with neoplasms and those without them. ⋯ The following authors have nothing to disclose: María del Carmen García García, Jacinto Hernández Borge, Pedro Pires Goncalves, Lourdes Cañón Barroso, Estefanía Molina Ortiz, Ana Castañar Jover, Francisca Lourdes Márquez Pérez, María José Antona Rodríguez, José Antonio Gutierrez Lara, Ignacio Rodríguez BlancoNo Product/Research Disclosure Information.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The effects of meteorological conditions on the frequency of COPD (chronic obstructive pulmonary disease) exacerbations. ⋯ The following authors have nothing to disclose: Burhan Akbas, Arzu MiriciNo Product/Research Disclosure Information.
-
Bronchiectasis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Evaluate the characteristics of patients with chronic obstructive pulmonary disease (COPD) and bronchiectasis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Daniel Coutinho, Daniel Vaz, Maria do Céu BritoNo Product/Research Disclosure Information.
-
Reg Anesth Pain Med · Mar 2014
Case ReportsDyskinesia Caused by Ziconotide-Baclofen Combination in an Adolescent Affected by Cerebral Palsy.
To report on the first case of ziconotide-induced dyskinesia. Ziconotide, a synthetic peptide analogue of the ω-conotoxin MVIIA that blocks selectively N-type voltage-sensitive calcium channels, has been used in intrathecal administration for 30 years. Ziconotide is a drug of choice for chronic pain because of its efficacy and flexibility because it can substitute or complement other intrathecal therapies including morphine or baclofen. Whereas substantial information is available regarding its efficacy, systematic data regarding the safety of ziconotide remain scant. The adverse reactions to ziconotide described so far regard only the coordination and execution of intentional movements. ⋯ An analysis of the signaling pathways of baclofen and ziconotide revealed a possible drug interaction that allowed ziconotide to trigger dyskinesia.